Literature DB >> 8155050

Pattern reversal visual evoked potentials following early treatment of unilateral, congenital cataract.

D L McCulloch1, B Skarf.   

Abstract

OBJECTIVE: To describe the pattern reversal visual evoked potentials (VEPs) that were used to monitor and quantify early visual development following treatment for dense, unilateral, congenital cataract.
DESIGN: Longitudinal prospective study. PATIENTS: Six infants who underwent surgery and contact lens correction before age 5 months and who had good compliance with occlusion therapy throughout the first 3 years of life.
RESULTS: Initially, VEPs from aphakic eyes showed marked abnormalities, including small amplitudes, prolonged latencies, missing components, and absent VEPs to small check sizes. Threshold check size was elevated by 3 octaves or more. With part-time occlusion of the opposite eye, VEPs normalized rapidly in the first year, but residual deficits remained to age 4 years when visual acuities were between 20/50 and 20/120 in aphakic eyes. Threshold check size clearly differentiated between aphakic and normal eyes and was the only VEP parameter that was correlated with single-letter visual acuity. Thus, threshold check size had greater clinical use than measures of pattern VEPs based on latency, amplitude, or waveform.
CONCLUSIONS: Patients treated for unilateral congenital cataract, who have early surgery and contact lens correction and comply with occlusion therapy, show a period of rapid VEP maturation and have a good visual prognosis.

Entities:  

Mesh:

Year:  1994        PMID: 8155050     DOI: 10.1001/archopht.1994.01090160086026

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  11 in total

Review 1.  Should we aggressively treat unilateral congenital cataracts?

Authors:  D Taylor; K W Wright; L Amaya; L Cassidy; K Nischal; I Russell-Eggitt; S Lightman; P McCluskey
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

2.  EEG alpha rhythms and transient chromatic and achromatic pattern visual evoked potentials in children and adults.

Authors:  Mei Ying Boon; Kar Ying Chan; Jaclyn Chiang; Rebecca Milston; Catherine Suttle
Journal:  Doc Ophthalmol       Date:  2011-03-03       Impact factor: 2.379

Review 3.  Occlusion for stimulus deprivation amblyopia.

Authors:  Aileen Antonio-Santos; Satyanarayana S Vedula; Sarah R Hatt; Christine Powell
Journal:  Cochrane Database Syst Rev       Date:  2014-02-06

Review 4.  Assessment of visual acuity in multiply handicapped children.

Authors:  R T Mackie; D L McCulloch
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

Review 5.  Interventions for stimulus deprivation amblyopia.

Authors:  S Hatt; A Antonio-Santos; C Powell; S S Vedula
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

6.  Visual acuity in unilateral cataract.

Authors:  D A Thompson; H Møller; I Russell-Eggitt; A Kriss
Journal:  Br J Ophthalmol       Date:  1996-09       Impact factor: 4.638

Review 7.  VEP estimation of visual acuity: a systematic review.

Authors:  Ruth Hamilton; Michael Bach; Sven P Heinrich; Michael B Hoffmann; J Vernon Odom; Daphne L McCulloch; Dorothy A Thompson
Journal:  Doc Ophthalmol       Date:  2020-06-02       Impact factor: 2.379

Review 8.  Pediatric cataract: challenges and future directions.

Authors:  Anagha Medsinge; Ken K Nischal
Journal:  Clin Ophthalmol       Date:  2015-01-07

9.  Fractal Dimension Analysis of Transient Visual Evoked Potentials: Optimisation and Applications.

Authors:  Mei Ying Boon; Bruce Ian Henry; Byoung Sun Chu; Nour Basahi; Catherine May Suttle; Chi Luu; Harry Leung; Stephen Hing
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

10.  Impairments of Visual Function and Ocular Structure in Patients With Unilateral Posterior Lens Opacity.

Authors:  Duoru Lin; Jingjing Chen; Zhenzhen Liu; Zhuoling Lin; Xiaoyan Li; Xiaohang Wu; Qianzhong Cao; Haotian Lin; Weirong Chen; Yizhi Liu
Journal:  Transl Vis Sci Technol       Date:  2018-07-24       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.